“Rheumatologic Consequences of Immune Checkpoint Inhibitors”, Annual Kessler Lecture, Dr. Ami Shah

Debate: Targeting the immune system with checkpoint inhibitors - Combination therapyПодробнее

CV Impact of Immune Checkpoint Inhibitor CardiotoxicityПодробнее

Glyco-checkpoints as Therapeutic Targets in Cancer, Autoimmunity & Infection by Dr. G. RabinovichПодробнее

iRAEs, Treatments for Checkpoint Inhibitor Inflammatory Arthritis and PMRПодробнее

Adverse effects of immune checkpoint inhibitorsПодробнее

Immune Checkpoint Inhibitors with Dr. Kerry ReynoldsПодробнее

Immune Checkpoint Inhibitor Toxicities in the ICU: A review - SJHH Medical Grand RoundsПодробнее

Checkpoint Inhibitors and Associated Rheumatic Disease_19th LMLRПодробнее

Immune Checkpoint Inhibitors: The Good, the Bad, and the Emerging Field of Cardio-OncologyПодробнее

Dissecting Toxicities of Immune Checkpoint Inhibitors with Dr. Douglas Johnson, M.D., MSCIПодробнее

Side effects of immune checkpoint inhibitorsПодробнее

Managing toxicities associated with immune-checkpoint inhibitorsПодробнее

Improving the Management of Cardiac Immune-Related Adverse Events in Patients With CancerПодробнее

Understanding Inflammatory Arthritis in Cancer Patients Caused by Checkpoint Inhibitors (:18)Подробнее

Severity of immune checkpoint inhibitors' side effectsПодробнее

Immune adverse events of checkpoint inhibitorsПодробнее

Immune checkpoint inhibitors in acute leukemiaПодробнее